Fulgent Genetics (7F0) Revenue
Fulgent Genetics Revenue
Fulgent Genetics had a revenue of 85.39M in the quarter ending Jun 30, 2026, with 20.03%. This bring the company's revenue in the last twelve months to 323.93M, Increased 1.12%. In the fiscal year ending Dec 31, 2025, Fulgent Genetics had annual revenue of 322.67M with 13.83% growth.
- Revenue (ttm)
- 323.93M
- Revenue Growth
- -0.34%
- P/S Ratio
- 1.57
- Revenue/Employee
- EUR 245,377
- Employees
- 1,315
- Market Cap
- EUR 506.32M
Revenue Chart
Fulgent Genetics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 322.67M | 39.20M | 13.83% |
| Dec 31, 2024 | 283.47M | -5.74M | -1.99% |
| Dec 31, 2023 | 289.21M | -329.75M | -53.27% |
| Dec 31, 2022 | 618.97M | -373.62M | -37.64% |
| Dec 31, 2021 | 992.58M | 570.87M | 135.37% |
| Dec 31, 2020 | 421.71M | 389.18M | 1196.46% |
| Dec 31, 2019 | 32.53M | 11.17M | 52.31% |
| Dec 31, 2018 | 21.36M | 2.63M | 14.03% |
| Dec 31, 2017 | 18.73M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.